Priscilla Sete de Carvalho Onofre

Priscilla Sete de Carvalho Onofre

Auto-generated profile, based on publicly available information

Priscilla Sete de Carvalho Onofre

Enfermeira Obstétrica e Doutora em Ciências. Escola Paulista de Enfermagem da Universidade Federal de São Paulo (EPE/UNIFESP). São Paulo - SP; Brasil

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Revista Latino-Americana de Enfermagem
Verified
Journal Article
Open access
DBDaniele Porto Barros
Daniele Porto Barros
POPriscilla Sete de Carvalho Onofre
Priscilla Sete de Carvalho Onofre
FFFernando Luiz Affonso Fonseca
Fernando Luiz Affonso Fonseca
PRPaulo César Pires Rosa
Paulo César Pires Rosa
MPMavilde Luz goncalves Pedreira
Mavilde Luz goncalves Pedreira
MPMaria Angélica Sorgini Peterlini
Maria Angélica Sorgini Peterlini
Resumo Objetivo: verificar a estabilidade do cloridrato de vancomicina em soluções de selo antimicrobiano sem e com associação de heparina sódica segundo a temperatura e tempo de associação. Método: estudo experimental delineado para análise de potencial hidrogeniônico e concentração por cromatografia líquida de alta eficiência de soluções de cloridrato de vancomicina (n=06) e cloridrato de vancomicina e heparina sódica (n=06). Submeteram-se as soluções estudadas à ausência de luz, 22°C e 37°C. Análises em triplicadas (n=192) ocorreram no momento inicial (T0), três (T3), oito (T8) e 24 horas (T24) após preparo. Os dados foram submetidos à análise de variância (p≤0,05). Resultados: a concentração do antimicrobiano a 22°C apresentou redução (T0-T8) e posterior elevação (T24); o potencial hidrogeniônico diminuiu significativamente ao longo do tempo. Em 37°C a concentração aumentou em até T3 e reduziu em T24, com redução de potencial hidrogeniônico até 24 horas. A concentração das soluções de cloridrato de vancomicina e heparina sódica apresentaram variação com redução a 22°C acompanhada de aumento de potencial hidrogeniônico. Observou-se formação de precipitado por inspeção visual da associação cloridrato de vancomicina e heparina sódica (T3). Conclusão: evidenciou-se estabilidade farmacológica do cloridrato de vancomicina (5 mg/mL) e incompatibilidade física com heparina sódica (100 UI/mL) após três horas de associação nas soluções de selo antimicrobiano estudadas.

2 March 2023 in Brazilian Journal of Analytical Chemistry
Verified
Journal Article
Closed access
POPriscilla Onofre
Priscilla Onofre
DBDaniele Barros
Daniele Barros
GSGabriela Trindade de Souza e Silva
Gabriela Trindade de Souza e Silva
FFFernando Luiz Affonso Fonseca
Fernando Luiz Affonso Fonseca
PRPaulo Rosa
Paulo Rosa
MPMaria Angélica Peterlini
Maria Angélica Peterlini
Vancomycin hydrochloride is a tricyclic glycopeptide that contains amino acids and sugars. This substance is indicated to treat serious infections caused by Gram-positive bacteria by intravenous infusion. The objective of this study was to develop and validate an analytical methodology by high performance liquid chromatography with ultraviolet detection (HPLC-UV) to determine vancomycin hydrochloride content by assessing the parameters of selectivity, linearity, working range, matrix effect, robustness, precision, and accuracy. The sample used was vancomycin hydrochloride in a vial and analyzes were carried out on HPLC-UV system, with C18 reverse-phase column at 30 °C, pH=4 and diode-array detection (220 nm). The mobile phase was composed of acetonitrile and monobasic ammonium phosphate buffer (8:92 v/v), 1 mL min-1 flow, injection volume of 20 μL and 15 minute of run time. The method has been shown to be selective, free from mobile phase interference, diluent and other substances on vancomycin hydrochloride retention time; the method is linear in the range between 25 and 175 µg mL-1; matrix effect showed parallelism between the lines, thus indicating the absence of interference of the matrix constituents in analysis of the compound of interest; the method was robust with drug variations proportional to the deliberate changes caused by the change in the flow rate of the mobile phase and in the column temperature; the method showed accuracy at 25, 50, and 75 µg mL-1 concentrations, showing satisfactory recovery rate after addition of the standard. The analytical methodology described proved to be simple, fast, safe and was considered valid.

27 January 2025 in Saúde Coletiva (Barueri)
Verified
Journal Article
Open access
PDF file
GSGustavo Gonçalves dos Santos
Gustavo Gonçalves dos Santos
HJHERLA MARIA F JORGE
HERLA MARIA F JORGE
PAPriscila de Souza Aquino
Priscila de Souza Aquino
POPriscilla Sete de Carvalho Onofre
Priscilla Sete de Carvalho Onofre
LETICIA LÓPEZ-PEDRAZALETICIA LÓPEZ-PEDRAZA
LETICIA LÓPEZ-PEDRAZA
GVGiovana Aparecida Gonçalves Vidotti
Giovana Aparecida Gonçalves Vidotti
Objetivo: Analisar a infecção e mortalidade por COVID-19 em mulheres brasileiras em idade reprodutiva, segundo a cor da pele, entre 2020 e 2024, utilizando dados do Observatório Obstétrico Brasileiro (OOBr). Método: Trata-se de um estudo transversal descritivo e exploratório, de base populacional, realizado a partir de dados secundários do OOBr. A coleta de dados abrangeu o período de janeiro de 2020 a maio de 2024, incluindo informações demográficas e clínicas de mulheres hospitalizadas com COVID-19 no Brasil. Foram realizadas análises descritivas e bivariadas para identificar associações significativas entre variáveis sociodemográficas e desfechos clínicos. Resultados: Mulheres pretas e pardas apresentaram taxas significativamente mais altas de hospitalização, necessidade de suporte ventilatório e mortalidade em comparação com mulheres brancas. Conclusão: O estudo destaca a necessidade urgente de políticas públicas focadas na equidade racial em saúde. Melhorias no acesso a cuidados de saúde, controle eficaz de comorbidades e estratégias de vacinação equitativas.

1 January 2025 in Acta Paulista de Enfermagem
Verified
Journal Article
Open access
PDF file
POPriscilla Sete de Carvalho Onofre
Priscilla Sete de Carvalho Onofre
DBDaniele Porto Barros
Daniele Porto Barros
GSGabriela Trindade de Souza e Silva
Gabriela Trindade de Souza e Silva
FFFernando Luiz Affonso Fonseca
Fernando Luiz Affonso Fonseca
PRPaulo Cesar Pires Rosa
Paulo Cesar Pires Rosa
MPMaria Angélica Sorgini Peterlini
Maria Angélica Sorgini Peterlini
Objective To evaluate the behavior of vancomycin solutions in different concentrations (5 mg/mL and 10 mg/mL) and under various temperature conditions (22ºC and 37ºC) at infusion times of zero (T0), two(T2) and four(T4) hours. Methods The experiment simulated clinical practice of vancomycin infusion. Antimicrobials were diluted at 5 and 10mg/mL, studied according to temperature variations (22°C and 37°C), and submitted to analyses immediately after preparation (T0), T2 and T4 hours of environmental exposure. The high-performance liquid chromatography method determined concentration and stability. A total of 108 concentrations and 36 pH measurements were analyzed for mean, standard deviation, ANOVA, and p≤0.05. Results The pH values did not show statistically significant variations during the four hours maintaining the acidic characteristic. There were no significant variations of vancomycin 5mg/mL at 22°C at T0 and T2, but there was a statistically significant concentration reduction at T4(<0.001). For vancomycin at 10mg/mL and 22°C, the active compound had an increase in concentration from T0 to T2, with a further decrease at T4(p=0.006); in 37°C there was a significant in concentration in T2 and T4(p<0.001). Conclusion Vancomycin at 5mg/mL showed significant concentration reduction in the fourth infusion hour. For vancomycin at 10mg/ml, there was an increase in concentration in the first two hours of analysis. There were statistically significant variations in vancomycin concentrations over time and in the experimental situations studied. Despite these variations, all changes remained within the 7% threshold accepted by the European Pharmacopeia, indicating that vancomycin stability is adequate for clinical use under the tested conditions.

1 January 2022 in Revista Latino-Americana de Enfermagem
Verified
Journal Article
Open access
DBDaniele Porto Barros
Daniele Porto Barros
POPriscilla Sete de Carvalho Onofre
Priscilla Sete de Carvalho Onofre
FFFernando Luiz Affonso Fonseca
Fernando Luiz Affonso Fonseca
PRPaulo César Pires Rosa
Paulo César Pires Rosa
MPMavilde Luz goncalves Pedreira
Mavilde Luz goncalves Pedreira
MPMaria Angélica Sorgini Peterlini
Maria Angélica Sorgini Peterlini
Resumen Objetivo: verificar la estabilidad del clorhidrato de vancomicina en soluciones de sellado antimicrobiano solo y combinado con heparina sódica según la temperatura y el tiempo de combinación. Método: estudio experimental diseñado para analizar el potencial de hidrógeno y la concentración por cromatografía líquida de alta resolución de soluciones de clorhidrato de vancomicina (n=06) y de clorhidrato de vancomicina y heparina sódica (n=06). Las soluciones estudiadas fueron sometidas a ausencia de luz, 22°C y 37°C. Se realizaron análisis por triplicado (n=192) en el momento inicial (T0), a las tres (T3), ocho (T8) y 24 horas (T24) después de la preparación. Los datos fueron sometidos a análisis de varianza (p≤0,05). Resultados: la concentración de antimicrobiano a 22°C mostró una reducción (T0-T8) y un posterior aumento (T24); el potencial de hidrógeno disminuyó significativamente con el tiempo. A 37°C, la concentración aumentó hasta T3 y disminuyó en T24, el potencial de hidrógeno disminuyó hasta las 24 horas. La concentración de las soluciones de clorhidrato de vancomicina y heparina sódica mostró variación con la reducción a 22°C acompañada de un aumento del potencial de hidrógeno. Mediante inspección visual se observó la formación de un precipitado al combinar clorhidrato de vancomicina y heparina sódica (T3). Conclusión: el clorhidrato de vancomicina (5 mg/ml) presentó evidencia de estabilidad farmacológica e incompatibilidad física con la heparina sódica (100 UI/ml) después de las tres horas de haberse realizado la combinación en las soluciones de sellado antimicrobiano estudiadas.

1 January 2022 in Revista Latino-Americana de Enfermagem
Verified
Journal Article
Open access
DBDaniele Porto Barros
Daniele Porto Barros
POPriscilla Sete de Carvalho Onofre
Priscilla Sete de Carvalho Onofre
FFFernando Luiz Affonso Fonseca
Fernando Luiz Affonso Fonseca
PRPaulo César Pires Rosa
Paulo César Pires Rosa
MPMavilde Luz goncalves Pedreira
Mavilde Luz goncalves Pedreira
MPMaria Angélica Sorgini Peterlini
Maria Angélica Sorgini Peterlini
Objective: to verify the stability of vancomycin hydrochloride in antimicrobial seal solutions with and without association of heparin sodium according to temperature and association time. Method: an experimental study designed for the analysis of hydrogenionic potential and concentration by means of high-efficiency liquid chromatography of vancomycin hydrochloride (n=06) and vancomycin hydrochloride and heparin sodium (n=06). The solutions studied were submitted to absence of light, as well as to 22°C and 37°C. Analyses in triplicate (n=192) were performed at the initial moment (T0) and three (T3), eight (T8) and 24 hours (T24) after preparation. The data were submitted to analysis of variance (p≤0.05). Results: concentration of the antimicrobial at 22°C presented a reduction (T0-T8) and a subsequent increase (T24); hydrogenionic potential decreased significantly over time. At 37°C, the concentration increased up to T3 and decreased at T24, with a reduction of hydrogenionic potential up to 24 hours. Concentration of the vancomycin hydrochloride and heparin sodium solutions varied with a reduction at 22°C, accompanied by increased hydrogenionic potential. Precipitate formation was observed by visual inspection of the vancomycin hydrochloride-heparin sodium association (T3). Conclusion: pharmacological stability of vancomycin hydrochloride (5 mg/mL) and physical incompatibility with heparin sodium (100 IU/mL) were evidenced after three hours of association in the antimicrobial seal solutions studied.